Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic Leukemia

NCT06299540 · clinicaltrials.gov ↗

RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell

Interventions

BEHAVIORAL: Individual Physical Activity Intervention (IPAI)
DRUG: Ibrutinib

Sponsor

Janssen Cilag S.A.S.